Biopharma

CA-125 Levels Vary by Patient Race at Ovarian Cancer Diagnosis

CA-125 Levels Vary by Patient Race at Ovarian Cancer Di...

Mar 24, 2025 0

MONDAY, March 24, 2025 -- Black and American Indian patients are less likely to...

Prevalence, Severity of Pediatric Astigmatism Increased After Pandemic

Prevalence, Severity of Pediatric Astigmatism Increased...

Mar 24, 2025 0

MONDAY, March 24, 2025 -- The prevalence and severity of refractive astigmatism...

Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms

Gender-Affirming Hormone Therapy in Primary Care Tied t...

Mar 24, 2025 0

MONDAY, March 24, 2025 -- Gender-affirming hormone therapy (GAHT) in primary ca...

Exposure to Maternal Cannabis Use Disorder Ups Risk for Youth Behavioral Disorders

Exposure to Maternal Cannabis Use Disorder Ups Risk for...

Mar 24, 2025 0

MONDAY, March 24, 2025 -- Children exposed to maternal cannabis use disorder (C...

Lifetime Excess Weight, Adult Weight Gain Linked to Increased Renal Cancer Risk

Lifetime Excess Weight, Adult Weight Gain Linked to Inc...

Mar 24, 2025 0

MONDAY, March 24, 2025 -- Lifetime excess weight and adult weight gain are asso...

Plant-Based Diets Increase Odds of Healthy Aging

Plant-Based Diets Increase Odds of Healthy Aging

Mar 24, 2025 0

MONDAY, March 24, 2025 -- Higher adherence to plant-based diets is associated w...

Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD

Chronic Conditions and Their Age of Onset Predict Healt...

Mar 24, 2025 0

MONDAY, March 24, 2025 -- Among people with inflammatory bowel disease (IBD), c...

Eyeing blockbuster sales, Harmony names Takeda veteran Zaeske chief commercial officer

Eyeing blockbuster sales, Harmony names Takeda veteran ...

Mar 24, 2025 0

Harmony Biosciences has named Adam Zaeske its chief commercial officer, luring t...

STAT+: MA anticipation, and security as a cost of doing business

STAT+: MA anticipation, and security as a cost of doing...

Mar 24, 2025 0

This week in healthcare business news: Changes are coming to Medicare Advantage,...

STAT+: Alnylam enters the ATTR-CM drug race

STAT+: Alnylam enters the ATTR-CM drug race

Mar 24, 2025 0

Today in "The Readout" newsletter: Alnylam's Amvuttra enters ATTR-CM drug race, ...

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0037/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 24, 2025 0

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemacicli...

Novo adds to obesity drug pipeline via $200M deal with China-based biotech

Novo adds to obesity drug pipeline via $200M deal with ...

Mar 24, 2025 0

The licensing pact adds a second so-called "triple agonist" to the Danish drugma...

Paediatric investigation plans: questions and answers

Paediatric investigation plans: questions and answers

Mar 24, 2025 0

Paediatric investigation plans: questions and answers

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025 0

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, ...

Tempero Bio gets $70M to advance substance abuse treatment

Tempero Bio gets $70M to advance substance abuse treatment

Mar 24, 2025 0

The Series B round will help the Aditum Bio-backed startup fund two mid-stage cl...

Biogen plots new global headquarters in Kendall Square

Biogen plots new global headquarters in Kendall Square

Mar 24, 2025 0

The big biotech signed a 15-year lease for approximately 580,000-square-feet of ...

Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025 0

Human medicines European public assessment report (EPAR): Seladelpar Gilead, Sel...

Opinion/decision on a Paediatric investigation plan (PIP): Exparel liposomal, bupivacaine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pain, PIP number: P/0021/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 24, 2025 0

Opinion/decision on a Paediatric investigation plan (PIP): Exparel liposomal, bu...

Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025 0

Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacteri...

Opinion/decision on a Paediatric investigation plan (PIP): Blincyto, blinatumomab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Blood and lymphatic system disorders, PIP number: P/0040/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 24, 2025 0

Opinion/decision on a Paediatric investigation plan (PIP): Blincyto, blinatumoma...

Gavi terminates COVID vaccine deal with Clover, demands $224M repayment

Gavi terminates COVID vaccine deal with Clover, demands...

Mar 24, 2025 0

International vaccine partnership Gavi has discontinued a COVID vaccine advance ...

Can philanthropy rescue struggling small biotechs?

Can philanthropy rescue struggling small biotechs?

Mar 24, 2025 0

Can philanthropy rescue struggling small biotechs? Authors of a new essay believ...

After Starboard Value gets a seat on the board, another activist investor rallies for change at Kenvue: Bloomberg

After Starboard Value gets a seat on the board, another...

Mar 24, 2025 0

TOMS Capital Investment Management picked up a stake at the consumer health drug...

Bharat Biotech enters cell and gene therapy market with $75M production investment: reports

Bharat Biotech enters cell and gene therapy market with...

Mar 24, 2025 0

Bharat Biotech is pumping $75 million into a new cell and gene therapy manufactu...

74
75
76
77
78

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.